122 related articles for article (PubMed ID: 19664348)
1. Simultaneous transurethral resection of prostate and prostate needle biopsy in patients with acute urinary retention and elevated prostate specific antigen levels.
Chen YT; Chiang PH; Hsu CC
Chang Gung Med J; 2009; 32(4):417-22. PubMed ID: 19664348
[TBL] [Abstract][Full Text] [Related]
2. Concomitant transrectal ultrasound-guided biopsy and transurethral resection of prostate in patients with urinary retention and elevated serum prostate-specific antigen levels.
Yang TY; Chow YC; Lin WR; Ko MC; Chen M; Chang HK; Hsu JM; Yang S; Lin WC; Chiu AW
J Chin Med Assoc; 2016 Nov; 79(11):605-608. PubMed ID: 27344217
[TBL] [Abstract][Full Text] [Related]
3. Acute urinary retention increases the risk of complications after transurethral resection of the prostate: a population-based study.
Chen JS; Chang CH; Yang WH; Kao YH
BJU Int; 2012 Dec; 110(11 Pt C):E896-901. PubMed ID: 23035623
[TBL] [Abstract][Full Text] [Related]
4. Comparison of transrectal ultrasound-guided biopsy of the prostate and transurethral resection of the prostate for detection of prostate cancer in patients with moderate lower urinary tract symptoms.
Chen SS; Chiu LP; Chen KK
J Chin Med Assoc; 2010 Nov; 73(11):568-72. PubMed ID: 21093824
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of serum total and free prostate-specific antigen (PSA) after extended multisite prostate biopsy: Comparison among biopsy, transurethral resection of the prostate (TURP), and biopsy plus TURP.
Hara N; Koike H; Nobushita T; Miyajima N; Kawaguchi M; Nishiyama T; Takahashi K; Hohenfellner R
Urol Oncol; 2010; 28(4):355-9. PubMed ID: 19110451
[TBL] [Abstract][Full Text] [Related]
6. Could the sextant prostate biopsy be replaced by transurethral resection?
Startsev VY; Pouline I; Gorelov S; Merkulova R
Arch Ital Urol Androl; 2005 Dec; 77(4):194-8. PubMed ID: 16444931
[TBL] [Abstract][Full Text] [Related]
7. Importance of TURP in diagnosing prostate cancer in men with multiple negative biopsies.
Philip J; Dutta Roy S; Scally J; Foster CS; Javlé P
Prostate; 2005 Jul; 64(2):200-2. PubMed ID: 15712218
[TBL] [Abstract][Full Text] [Related]
8. Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: implications for clinical management.
Aydin H; Zhang J; Samaratunga H; Tan N; Magi-Galluzzi C; Klein E; Jones JS; Zhou M
BJU Int; 2010 Feb; 105(4):476-80. PubMed ID: 19709071
[TBL] [Abstract][Full Text] [Related]
9. Long-term clinical outcome of diagnostic transurethral resection of the prostate in patients with elevated prostate-specific antigen level and minor lower urinary tract symptoms.
van Renterghem K; van Koeveringe G; Achten R; van Kerrebroeck P
Urol Int; 2009; 83(1):60-5. PubMed ID: 19641361
[TBL] [Abstract][Full Text] [Related]
10. Risk of urinary incontinence following post-brachytherapy transurethral resection of the prostate and correlation with clinical and treatment parameters.
Mock S; Leapman M; Stock RG; Hall SJ; Stone NN
J Urol; 2013 Nov; 190(5):1805-10. PubMed ID: 23669568
[TBL] [Abstract][Full Text] [Related]
11. Relation between acute urinary retention, chronic prostatic inflammation and accompanying elevated prostate-specific antigen.
Kefi A; Koseoglu H; Celebi I; Yorukoglu K; Esen A
Scand J Urol Nephrol; 2006; 40(2):155-60. PubMed ID: 16608815
[TBL] [Abstract][Full Text] [Related]
12. Previous transurethral resection of the prostate is not a contraindication to high-dose rate brachytherapy for prostate cancer.
Luo HL; Fang FM; Chuang YC; Chiang PH
BJU Int; 2009 Dec; 104(11):1620-3. PubMed ID: 19624535
[TBL] [Abstract][Full Text] [Related]
13. Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy.
Kollmeier MA; Stock RG; Cesaretti J; Stone NN
J Urol; 2005 Mar; 173(3):808-12. PubMed ID: 15711274
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of transurethral resection of the prostate in "asymptomatic" patients with an elevated prostate-specific antigen level.
van Renterghem K; Van Koeveringe G; Achten R; Van Kerrebroeck P
Eur Urol; 2007 Sep; 52(3):819-26. PubMed ID: 17418482
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer. Mortality and morbidity after non-curative treatment with aspects on diagnosis and treatment.
Aus G
Scand J Urol Nephrol Suppl; 1994; 167():1-41. PubMed ID: 7542397
[TBL] [Abstract][Full Text] [Related]
16. Transurethral prostatic resection for acute urinary retention in patients with prostate cancer.
Chang CC; Kuo JY; Chen KK; Lin AT; Chang YH; Wu HH; Chang LS
J Chin Med Assoc; 2006 Jan; 69(1):21-5. PubMed ID: 16447922
[TBL] [Abstract][Full Text] [Related]
17. Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy.
Sciarra A; Panebianco V; Cattarino S; Busetto GM; De Berardinis E; Ciccariello M; Gentile V; Salciccia S
BJU Int; 2012 Dec; 110(11):1661-5. PubMed ID: 22564540
[TBL] [Abstract][Full Text] [Related]
18. Acute urinary retention after transperineal template-guided prostate biopsy.
Buskirk SJ; Pinkstaff DM; Petrou SP; Wehle MJ; Broderick GA; Young PR; Weigand SD; O'Brien PC; Igel TC
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1360-6. PubMed ID: 15275721
[TBL] [Abstract][Full Text] [Related]
19. Tumor cytoreduction results in better response to androgen ablation--a preliminary report of palliative transurethral resection of the prostate in metastatic hormone sensitive prostate cancer.
Qin XJ; Ma CG; Ye DW; Yao XD; Zhang SL; Dai B; Zhang HL; Shen YJ; Zhu Y; Zhu YP; Shi GH; Xiao WJ; Lin GW; Swanson GP
Urol Oncol; 2012; 30(2):145-9. PubMed ID: 20451424
[TBL] [Abstract][Full Text] [Related]
20. Altered prostate specific antigen reference range after transurethral resection of the prostate.
Wolff JM; Boekels O; Borchers H; Jakse G; Rohde D
Anticancer Res; 2000; 20(6D):4977-80. PubMed ID: 11326651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]